Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Upkar S Gill

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Gut|September 22, 2021
The human liver microenvironment shapes the homing and function of CD4<sup>+</sup> T-cell populationsBenjamin G Wiggins, Laura J Pallett, Xiaoyan Li, et al.
Gut|December 4, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infectionAnucha Preechanukul, Aljawharah Alrubayyi, Bo Sun, et al.
Biomedicines|October 23, 2021
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV ReactivationLorenzo Piermatteo, Mohammad Alkhatib, Stefano D'Anna, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infectionJay Preechanukul, Aljawharah Alrubayyi, Bo Sun, et al.
Journal of Hepatology|October 9, 2020
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyThomas Marjot, Andrew M Moon, Jonathan A Cook, et al.
Emerging Microbes & Infections|April 22, 2020
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels <i>in vivo</i>, hinder HBsAg secretion <i>in vitro</i> and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infectionRomina Salpini, Arianna Battisti, Lorenzo Piermatteo, et al.
Nature|January 25, 2023
Tissue CD14<sup>+</sup>CD8<sup>+</sup> T cells reprogrammed by myeloid cells and modulated by LPSLaura J Pallett, Leo Swadling, Mariana Diniz, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Gut|September 22, 2021
The human liver microenvironment shapes the homing and function of CD4<sup>+</sup> T-cell populationsBenjamin G Wiggins, Laura J Pallett, Xiaoyan Li, et al.
Gut|December 4, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infectionAnucha Preechanukul, Aljawharah Alrubayyi, Bo Sun, et al.
Biomedicines|October 23, 2021
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV ReactivationLorenzo Piermatteo, Mohammad Alkhatib, Stefano D'Anna, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infectionJay Preechanukul, Aljawharah Alrubayyi, Bo Sun, et al.
Journal of Hepatology|October 9, 2020
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyThomas Marjot, Andrew M Moon, Jonathan A Cook, et al.
Emerging Microbes & Infections|April 22, 2020
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels <i>in vivo</i>, hinder HBsAg secretion <i>in vitro</i> and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infectionRomina Salpini, Arianna Battisti, Lorenzo Piermatteo, et al.
Nature|January 25, 2023
Tissue CD14<sup>+</sup>CD8<sup>+</sup> T cells reprogrammed by myeloid cells and modulated by LPSLaura J Pallett, Leo Swadling, Mariana Diniz, et al.
Pageof 6